Quantcast

Latest polycythemia vera Stories

2015-04-22 04:21:49

-- Pacritinib Abstract #LBA7006 also to be Highlighted in the Official ASCO Press Program -- SEATTLE and DEERFIELD, Ill., April 22, 2015 /PRNewswire/ -- CTI BioPharma Corp.

2015-04-07 16:26:39

RnRMarketResearch.com adds "Polycythemia Vera - Pipeline Review, H1 2015" to its store.

2015-03-16 04:20:28

SEATTLE, March 16, 2015 /PRNewswire/ -- CTI BioPharma Corp.

2015-03-11 04:25:00

- PharmaEssentia and AOP Orphan announce completion of recruitment of the pivotal European Phase III trial PROUD-PV (www.proud-pv.com) to support global marketing of P1101 (Ropeginterferon alfa-2b).

2015-03-09 08:29:09

Trial Meets Primary Endpoint in Intent-to-Treat Population SEATTLE and DEERFIELD, Ill., March 9, 2015 /PRNewswire/ -- CTI BioPharma Corp.

2014-08-07 04:21:40

SEATTLE, Aug. 7, 2014 /PRNewswire/ --CTI BioPharma Corp. (CTI or the Company) (NASDAQ and MTA: CTIC) announced today that pacritinib has been granted Fast Track designation by the U.S.

2014-07-01 04:21:47

-Top-line Results Expected in Early 2015- SEATTLE, July 1, 2014 /PRNewswire/ -- CTI BioPharma Corp.

2014-05-07 23:11:40

MPN Research Foundation will accept the Abbey S.

2014-01-30 23:31:18

Following the discovery of the Calreticulin (CALR) mutation, which accounts for the majority of non JAK/MPL mutations in ET and MF patients, Dr.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related